Cargando…
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate
Chronic inflammation is a risk factor for the onset of cancer and the regular use of aspirin reduces the risk of cancer development. Here we showed that therapeutic dosages of aspirin counteract the pro-tumorigenic effects of the inflammatory cytokine interleukin(IL)-6 in cancer and non-cancer cell...
Autores principales: | Brighenti, Elisa, Giannone, Ferdinando Antonino, Fornari, Francesca, Onofrillo, Carmine, Govoni, Marzia, Montanaro, Lorenzo, Treré, Davide, Derenzini, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325359/ https://www.ncbi.nlm.nih.gov/pubmed/27557515 http://dx.doi.org/10.18632/oncotarget.11441 |
Ejemplares similares
-
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer
por: Brighenti, E, et al.
Publicado: (2014) -
The Ribosome Biogenesis—Cancer Connection
por: Penzo, Marianna, et al.
Publicado: (2019) -
Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?
por: Brighenti, Elisa, et al.
Publicado: (2015) -
The pre-existing population of 5S rRNA effects p53 stabilization during ribosome biogenesis inhibition
por: Onofrillo, Carmine, et al.
Publicado: (2016) -
Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why
por: Derenzini, Enrico, et al.
Publicado: (2018)